[{"type": "title", "data": "CARD ST-Elevation Myocardial Infarction (STEMI) Admission (Version 1.79)"}, {"type": "category", "data": "Medications"}, {"type": "note", "data": "Ensure initial doses of antiplatelets have been administered"}, {"type": "order", "data": "acetylsalicylic acid 81 mg oral enteric coated tablet", "value": "checked"}, {"type": "sentence", "data": "81 mg, PO, EC Tablet, Daily, 180 day(s)"}, {"type": "order", "data": "clopidogrel", "value": "checked"}, {"type": "sentence", "data": "75 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "note", "data": "For patients 75 years or less"}, {"type": "note", "data": "Ensure initial dose of anticoagulants have been administered "}, {"type": "order", "data": "enoxaparin", "value": ""}, {"type": "sentence", "data": "1 mg/kg, SubQ, Injection, q12hr(sched), 8 day(s)"}, {"type": "sentence", "data": "100 mg, SubQ, Injection, q12hr(sched), 8 day(s)"}, {"type": "note", "data": "carvedilol target dose: 25 mg PO BID "}, {"type": "order", "data": "carvedilol", "value": ""}, {"type": "sentence", "data": "3.125 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "sentence", "data": "6.25 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "sentence", "data": "12.5 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "sentence", "data": "25 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "sentence", "data": "50 mg, PO, Tab, BID(with meals), 180 day(s)"}, {"type": "note", "data": "bisOPROLOL target dose: 10 mg PO Daily"}, {"type": "order", "data": "bisoprolol", "value": ""}, {"type": "sentence", "data": "2.5 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "1.25 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "5 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "10 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "note", "data": "metoprolol target dose: 100 mg PO BID"}, {"type": "order", "data": "metoprolol", "value": ""}, {"type": "sentence", "data": "25 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "12.5 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "50 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "100 mg, PO, Tab, BID, 180 day(s)"}, {"type": "note", "data": "Re-assess therapy if serum creatinine increases by more than 30% or if serum potassium rises above 5.2 mmol/L"}, {"type": "order", "data": "ramipril", "value": ""}, {"type": "sentence", "data": "2.5 mg, PO, Cap, BID, 180 day(s)"}, {"type": "sentence", "data": "1.25 mg, PO, Cap, BID, 180 day(s)"}, {"type": "sentence", "data": "5 mg, PO, Cap, BID, 180 day(s)"}, {"type": "sentence", "data": "2.5 mg, PO, Cap, Daily, 180 day(s)"}, {"type": "sentence", "data": "5 mg, PO, Cap, Daily, 180 day(s)"}, {"type": "sentence", "data": "10 mg, PO, Cap, Daily, 180 day(s)"}, {"type": "order", "data": "perindopril", "value": ""}, {"type": "sentence", "data": "4 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "2 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "8 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "note", "data": "Avoid combination of ACE Inhibitor with ARB"}, {"type": "note", "data": "Angiotensin Receptor Blocker (ARB) - indicated for ACE- inhibitor intolerance"}, {"type": "note", "data": "Re-assess therapy if serum creatinine increases by more than 30% or if serum potassium rises above 5.2 mmol/L"}, {"type": "order", "data": "candesartan", "value": ""}, {"type": "sentence", "data": "8 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "4 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "16 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "32 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "order", "data": "valsartan", "value": ""}, {"type": "sentence", "data": "40 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "80 mg, PO, Tab, BID, 180 day(s)"}, {"type": "sentence", "data": "160 mg, PO, Tab, BID, 180 day(s)"}, {"type": "order", "data": "losartan", "value": ""}, {"type": "sentence", "data": "25 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "50 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "75 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "sentence", "data": "100 mg, PO, Tab, Daily, 180 day(s)"}, {"type": "note", "data": "Avoid nitroglycerin if any of the following are present:&nbsp;&nbsp; - SBP below 90 mmHg or if more than 30 mmHg drop from baseline&nbsp; - Suspected right ventricular infarction&nbsp; - Recent use of phosphodiesterase inhibitors; within 24 hours for sildenafil [VIAGRA] and vardenafil [LEVITRA]; within 48 hours for tadalafil [CIALIS]"}, {"type": "order", "data": "nitroglycerin 0.4 mg sublingual spray", "value": ""}, {"type": "sentence", "data": "0.4 mg, SL, Spray, q5min, PRN, Other (see Comment), 180 day(s)"}, {"type": "note", "data": "&quot;nitroglycerin titratable infusion (0.2 mg/ml) in d5w standard&quot; CIS Pharmacy to Update with IV Set When Built"}, {"type": "category", "data": "Diagnostic Tests"}, {"type": "order", "data": "Conditional Order", "value": ""}, {"type": "sentence", "data": "T;N, If/when fibrinolytic therapy is given, then RN to place an order for ECG Standard 12 Lead 60 minutes post administration"}, {"type": "category", "data": "Communication Orders"}, {"type": "order", "data": "Communication Order", "value": ""}, {"type": "sentence", "data": "Ensure an evaluation of Left Ventricular function is acquired prior to discharge"}]
